Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nabil Saba

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Current Problems in Cancer|June 15, 2010
ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomasHarry Quon, Sue S Yom, Madhur Kumar Garg, et al.
Head & Neck|January 18, 2012
ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil, Anamaria Reyna Yeung, Madhur Kumar Garg, et al.
Oral Oncology|June 14, 2011
ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck, Joseph K Salama, Nabil Saba, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2011
ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancerMark W McDonald, Joshua Lawson, Madhur Kumar Garg, et al.
Cancer|June 22, 2010
Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancerSuresh S Ramalingam, R Donald Harvey, Nabil Saba, et al.
Head & Neck|May 23, 2013
American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancerJohn A Ridge, Joshua Lawson, Sue S Yom, et al.
Oral Oncology|January 17, 2015
A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinomaJill Gilbert, Michael J Schell, Xiuhua Zhao, et al.
Oral Oncology|May 15, 2014
ACR Appropriateness Criteria® thyroid carcinomaJoseph K Salama, Daniel W Golden, Sue S Yom, et al.
Cancer|March 3, 2011
Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignanciesJohn Kauh, Chantal Chanel-Vos, Daniel Escuin, et al.
Oral Oncology|April 20, 2021
TORS elective lingual tonsillectomy has less acute morbidity than therapeutic base of tongue TORSMihir R Patel, Lauren Ottenstein, Martha Ryan, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Current Problems in Cancer|June 15, 2010
ACR Appropriateness Criteria: local-regional therapy for resectable oropharyngeal squamous cell carcinomasHarry Quon, Sue S Yom, Madhur Kumar Garg, et al.
Head & Neck|January 18, 2012
ACR Appropriateness Criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil, Anamaria Reyna Yeung, Madhur Kumar Garg, et al.
Oral Oncology|June 14, 2011
ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck, Joseph K Salama, Nabil Saba, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2011
ACR appropriateness criteria retreatment of recurrent head and neck cancer after prior definitive radiation expert panel on radiation oncology-head and neck cancerMark W McDonald, Joshua Lawson, Madhur Kumar Garg, et al.
Cancer|June 22, 2010
Phase 1 and pharmacokinetic study of everolimus, a mammalian target of rapamycin inhibitor, in combination with docetaxel for recurrent/refractory nonsmall cell lung cancerSuresh S Ramalingam, R Donald Harvey, Nabil Saba, et al.
Head & Neck|May 23, 2013
American College of Radiology Appropriateness Criteria(®) treatment of stage I T1 glottic cancerJohn A Ridge, Joshua Lawson, Sue S Yom, et al.
Oral Oncology|January 17, 2015
A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinomaJill Gilbert, Michael J Schell, Xiuhua Zhao, et al.
Oral Oncology|May 15, 2014
ACR Appropriateness Criteria® thyroid carcinomaJoseph K Salama, Daniel W Golden, Sue S Yom, et al.
Cancer|March 3, 2011
Farnesyl transferase expression determines clinical response to the docetaxel-lonafarnib combination in patients with advanced malignanciesJohn Kauh, Chantal Chanel-Vos, Daniel Escuin, et al.
Oral Oncology|April 20, 2021
TORS elective lingual tonsillectomy has less acute morbidity than therapeutic base of tongue TORSMihir R Patel, Lauren Ottenstein, Martha Ryan, et al.
Pageof 4